asthma drug strategy

Actionable Insights Powered by AI

Connect Biotech Scales Back in China, Reassesses Strategy for Asthma Drug to Compete with Dupixent

Connect Biotech, China workforce reduction, Dupixent rival, asthma drug strategy, biotech industry